MedTrace Logo

Antimullerian Hormone as an Indicator for Ovarian Response

NCT03291860 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2017-09-25

No results posted yet for this study

Summary

Anti Mullerian hormone (AMH) is gaining place as ovarian marker, chiefly in infertility assistance.

Investigators explored its correlation with oocytes retrieval after long GnRH agonist protocol for stimulation, in younger and older infertile population. Methods: This prospective analysis compiled data of 66 females, receiving ICSI treatment from April 2016 to October 2017. Serum FSH, LH, Estadiol, AMH and antral follicle count were assessed. Outcomes were measured as good (5 to 19 oocytes) and bad responders.

Conditions

  • Infertility, Female

Interventions

PROCEDURE

Ovum retrievum

assessment of oocytes collected by ovum retrievum to evaluate the discriminatory power of the antimullerian hormone in ICSI cycles

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-10
Primary Completion
2018-09-10
Completion
2018-10-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03291860 on ClinicalTrials.gov